AAAAAA

   
Results: 1-9 |
Results: 9
Skin lesions in malignancy case 3. Yellow nail syndrome in non-Hodgkin's lymphoma (vol 19, pg 2100, 2001)
Authors: Seve, P Thieblemont, C Dumontet, C Bouafia, F Arnaud, P Hequest, O Espinouse, D Salles, G Coiffier, B
Citation: P. Seve et al., Skin lesions in malignancy case 3. Yellow nail syndrome in non-Hodgkin's lymphoma (vol 19, pg 2100, 2001), J CL ONCOL, 19(11), 2001, pp. 2972-2972
Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma
Authors: Dumontet, C Morschhauser, F Solal-Celigny, P Bouafia, F Bourgeois, E Thieblemont, C Leleu, X Hequet, O Salles, G Coiffier, B
Citation: C. Dumontet et al., Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma, BR J HAEM, 113(3), 2001, pp. 772-778
The superoxide dismutase content in erythrocytes predicts short-term toxicity of high-dose cyclophosphamide
Authors: Dumontet, C Drai, J Thieblemont, C Hequet, O Espinouse, D Bouafia, F Salles, G Coiffier, B
Citation: C. Dumontet et al., The superoxide dismutase content in erythrocytes predicts short-term toxicity of high-dose cyclophosphamide, BR J HAEM, 112(2), 2001, pp. 405-409
A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors
Authors: Dumontet, C Thieblemont, C Espinouse, D Bouafia, F Hequet, O Salles, G Coiffier, B
Citation: C. Dumontet et al., A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors, LEUKEMIA, 14(12), 2000, pp. 2159-2165
Skin lesions in malignancy case 3. Yellow nail syndrome in non-Hodgkin's lymphoma
Authors: Steve, P Thieblemont, C Dumontet, C Bouafia, F Arnaud, P Hequet, O Espinouse, D Salles, G Coiffer, B
Citation: P. Steve et al., Skin lesions in malignancy case 3. Yellow nail syndrome in non-Hodgkin's lymphoma, J CL ONCOL, 19(7), 2000, pp. 2100-2101
Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed
Authors: Thieblemont, C Berger, F Dumontet, C Moullet, I Bouafia, F Felman, P Salles, G Coiffier, B
Citation: C. Thieblemont et al., Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed, BLOOD, 95(3), 2000, pp. 802-806
Profiles and prognostic values of LDH isoenzymes in patients lymphoma
Authors: Dumontet, C Drai, J Bienvenu, J Berard, EN Thieblemont, C Bouafia, F Bayle, F Moullet, I Salles, G Coiffier, B
Citation: C. Dumontet et al., Profiles and prognostic values of LDH isoenzymes in patients lymphoma, LEUKEMIA, 13(5), 1999, pp. 811-817
Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution
Authors: Ketterer, N Sonet, A Dumontet, C Moullet, I Thieblemont, C Espinouse, D Bouafia, F Coiffier, B Salles, G
Citation: N. Ketterer et al., Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution, BONE MAR TR, 23(12), 1999, pp. 1309-1315
Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: Etiology and potential risk factors
Authors: Ketterer, N Espinouse, D Chomarat, M Dumontet, C Moullet, I Rieux, C Neidhardt-Berard, EM Bouafia, F Coiffier, B Salles, G
Citation: N. Ketterer et al., Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: Etiology and potential risk factors, AM J MED, 106(2), 1999, pp. 191-197
Risultati: 1-9 |